SCHEMBL8549655

SCHEMBL8549655

CCCOc1ccc2[nH]cc(C(=O)C(=O)Cl)c2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.66
HTR1A P08908 7/20 0.53
HTR1B P28222 7/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPT P10636 2/20 0.52
MITF O75030 1/20 0.52
LMNA P02545 1/20 0.52
RAB9A P51151 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
NR4A2 P43354 1/20 0.48
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
ALDH1A1 P00352 1/20 0.47
HTR1D P28221 6/20 0.45
KDM4E B2RXH2 2/20 0.45
CPT1A P50416 1/20 0.45
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551129 0.85 HTT (0.63) HTTHTR1AHTR1BMEN1KMT2A
SCHEMBL7385581 0.82 LMNA (0.70) MEN1KMT2AMAPTMITFLMNA
SCHEMBL12721389 0.81 MAPT (0.71) HTTHTR1AHTR1BMEN1KMT2A
SCHEMBL11188479 0.80 HTR1D (0.54) HTTHTR1AHTR1BMEN1KMT2A
SCHEMBL11194622 0.80 ALDH1A1 (0.59) MEN1KMT2AMAPTCYP1A2CYP2C19
SCHEMBL2536598 0.78 RAB9A (0.50) MEN1KMT2AMAPTMITFLMNA
SCHEMBL28984932 0.77 MEN1 (0.49) HTTMEN1KMT2AMAPTMITF
SCHEMBL24855192 0.76 NR4A2 (0.50) HTR1AMEN1KMT2AMAPTMITF
SCHEMBL21547894 0.76 KDM4E (0.53) HTTMEN1KMT2AMAPTMITF
SCHEMBL2537388 0.76 HTR1D (0.50) HTR1BMEN1KMT2AMAPTMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593513-B1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1998-10-28 EP disclosed
US-5571833-A TREATMENT OF MIGRAINE, PORTAL HYPERTENSION SMITHKLINE BEECHAM PLC (GB) 1996-11-05 US disclosed
EP-0593513-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1994-04-27 EP disclosed
WO-1993000333-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-01-07 WO disclosed